Monday, March 17, 2025 | 01:34 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Six Indian drug firms that are doing serious business in coronavirus times

The world's race for a coronavirus drug hinges on Indian companies working with their global peers. Business Standard tracks six companies to feel the pulse of Indian pharma

covid, coronavirus, vaccine, drug, pharma
Premium

Indian pharma companies are working with global institutions to develop vaccines against the coronavirus disease Covid-19.

Ujjval Jauhari New Delhi
India’s pharmaceutical companies shine bright in the coronavirus pandemic, turning a corner after sweating it out in the coveted US market due to pricing pressure, consolidation and regulatory scrutiny.

The Food and Drug Administration (FDA), USA's regulator for drug and food safety, has sped up approvals for facilities of Indian drug manufacturers. Analysts say the pandemic has opened the door for Indian companies manufacturing a spectrum of drugs like hydroxychloroquine, the anti-malarial drug touted by US President Donald Trump as a potential “game changer” in the fight against the pandemic, and Remdesivir, the investigational antiviral drug.

Indian pharma companies are

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in